XNCR
XencorFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
XNCR vs peer average
15/100
XNCR vs. peer average (F vs. C)
Grade spread
A 3 · B 2 · C 1 · D 2 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ABUS is the first available peer comparator.
Small-cap clinical biotech comp by size, but not a close operating peer; useful mainly as a sentiment/risk benchmark for binary development-stage names.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
XNCR
Xencor
ABUS
Arbutus Biopharma
Grade
F
B
Momentum
96
27
Value
41
55
Sentiment
0
71
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs ABUS
XNCR / ABUS
Grade Position
Below peers
XNCR vs. peer average (F vs. C)
15/100
Momentum
96
XNCRValue
41
ABUSSentiment
0
ABUSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs XNCR
ABUS is the first peer returned for this comparison set.